Drug intelligence / Profile preview

hyaluronic acid + amino acid

Development stage
Unknown
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Intradermal (mesotherapy/injection), Powder (topical Application), Gel, Cream
01

Overview

The combination drug **hyaluronic acid + amino acid** consists of **hyaluronic acid** (HA), a naturally occurring glycosaminoglycan known for its remarkable water-retention and tissue hydration properties, and selected **amino acids** (such as glycine and proline, often key precursors in collagen synthesis). This combination is used primarily for skin and wound treatments where HA acts to hydrate the extracellular matrix and stimulate CD44 receptor pathways—promoting cell proliferation, migration, and extracellular matrix (ECM) bioregeneration. Amino acids further enhance this effect by directly supporting the synthesis of collagen and elastin, thereby improving skin structure, elasticity, and wound healing. Clinical evidence supports its efficacy and safety for management of skin damage from dehydration, UV exposure, aging, and various types of wounds (acute, chronic, diabetic, venous stasis ulcers, and post-surgical wounds)[1][2][4]. The medication is available in different forms, including injectable solutions (mesotherapy), powders, gels, and creams[2].

Brand names
SKIN RVulnamin
Other names
hyaluronic acid and amino acids mixtureHA + amino acidshyaluronic acid-amino acid combination
02

Targets

RHAMM (Hyaluronan-mediated motility receptor)CD44 (CD44 antigen)

Beyond the preview

Go deeper on hyaluronic acid + amino acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hyaluronic acid + amino acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call